Randomized clinical trial with two palliative radiotherapy regimens in painful bone metastases: 30 Gy in 10 fractions compared with 8 Gy in single fraction PF Arnalot, AV Fontanals, JC Galcerán, F Lynd, XS Latiesas, NR de Dios, ... Radiotherapy and oncology 89 (2), 150-155, 2008 | 236 | 2008 |
Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis DA Palma, S Senan, C Oberije, J Belderbos, NR De Dios, JD Bradley, ... International Journal of Radiation Oncology* Biology* Physics 87 (4), 690-696, 2013 | 189 | 2013 |
Randomized phase III trial of prophylactic cranial irradiation with or without hippocampal avoidance for small-cell lung cancer (PREMER): a GICOR-GOECP-SEOR study N Rodríguez de Dios, F Couñago, M Murcia-Mejía, M Rico-Oses, ... Journal of Clinical Oncology 39 (28), 3118-3127, 2021 | 94 | 2021 |
Multidisciplinary consensus statement on the clinical management of patients with stage III non-small cell lung cancer M Majem, J Hernández-Hernández, F Hernando-Trancho, ... Clinical and Translational Oncology 22, 21-36, 2020 | 55 | 2020 |
Factors associated with early mortality in patients treated with concurrent chemoradiation therapy for locally advanced non-small cell lung cancer A Warner, M Dahele, B Hu, DA Palma, S Senan, C Oberije, K Tsujino, ... International Journal of Radiation Oncology* Biology* Physics 94 (3), 612-620, 2016 | 44 | 2016 |
Neoadjuvant treatment followed by surgery versus definitive chemoradiation in stage IIIA-N2 non-small-cell lung cancer: A multi-institutional study by the oncologic group for … F Couñago, NR de Dios, S Montemuiño, J Jové-Teixidó, M Martin, ... Lung Cancer 118, 119-127, 2018 | 33 | 2018 |
Phase III trial of prophylactic cranial irradiation with or without hippocampal avoidance for small-cell lung cancer NR De Dios, M Murcia, F Counago, J Lopez, MR Oses, PMS Ots, ... International Journal of Radiation Oncology, Biology, Physics 105 (1), S35-S36, 2019 | 31 | 2019 |
Impact of 18F-FDG PET/CT on the treatment of patients with non-small cell lung cancer Á Taus, R Aguiló, V Curull, M Suarez-Pinera, A Rodríguez-Fuster, ... Archivos de Bronconeumología (English Edition) 50 (3), 99-104, 2014 | 31 | 2014 |
Risk factors of local relapse in breast cancer: the importance of age M Algara López, X Sanz Latiesas, P Foro Arnalot, M Lacruz Bassols, ... Clinical and Translational Oncology 9, 110-116, 2007 | 30 | 2007 |
Prevention of acute radiation enteritis: efficacy and tolerance of glutamine I Membrive Conejo, A Reig Castillejo, N Rodríguez de Dios, ... Clinical and Translational Oncology 13, 760-763, 2011 | 26 | 2011 |
Treatment design and rationale for a randomized trial of prophylactic cranial irradiation with or without hippocampal avoidance for SCLC: PREMER trial on behalf of the … NR de Dios, F Couñago, JL López, P Calvo, M Murcia, M Rico, C Vallejo, ... Clinical Lung Cancer 19 (5), e693-e697, 2018 | 22 | 2018 |
Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non–small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis G Rodrigues, C Oberije, S Senan, K Tsujino, T Wiersma, ... International Journal of Radiation Oncology* Biology* Physics 91 (1), 133-139, 2015 | 22 | 2015 |
Noninvasive ablation of ventricular tachycardia with stereotactic radiotherapy in a patient with arrhythmogenic right ventricular cardiomyopathy J Martí-Almor, J Jiménez-López, NR de Dios, H Tizón, E Vallés, M Algara Revista espanola de cardiologia (English ed.) 73 (1), 97-99, 2020 | 21 | 2020 |
Targeted therapy combined with radiotherapy in non-small-cell lung cancer: a review of the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society) F Couñago, A Rodríguez, P Calvo, J Luna, JL Monroy, B Taboada, V Díaz, ... Clinical and Translational Oncology 19, 31-43, 2017 | 20 | 2017 |
Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of … F Couñago, S Montemuiño, M Martin, B Taboada, P Calvo-Crespo, ... Clinical and Translational Oncology 21, 735-744, 2019 | 17 | 2019 |
GOECP/SEOR clinical recommendations for lung cancer radiotherapy during the COVID-19 pandemic F Couñago, A Navarro-Martin, J Luna, NR de Dios, A Rodríguez, F Casas, ... World Journal of Clinical Oncology 11 (8), 510, 2020 | 16 | 2020 |
Neuroendocrine small cell carcinoma of the uterine cervix A Reig Castillejo, I Membrive Conejo, P Foro Arnalot, ... Clinical and Translational Oncology 12, 512-513, 2010 | 16 | 2010 |
Accelerated hypofractionated radiation therapy (AHRT) for non-small-cell lung cancer: can we leave standard fractionation? NR de Dios, X Sanz, P Foro, I Membrive, A Reig, A Ortiz, R Jiménez, ... Clinical and Translational Oncology 19, 440-447, 2017 | 14 | 2017 |
High-dose neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery in potentially-resectable stage IIIA-N2 NSCLC. A multi-institutional retrospective study … S Montemuiño, NR Dios, M Martín, B Taboada, P Calvo-Crespo, ... Reports of Practical Oncology and Radiotherapy 25 (3), 447-455, 2020 | 12 | 2020 |
Use of radiation treatment units in breast cancer. Changes in the last 15 years MA López, XS Latiesas, PF Arnalot, ML Bassols, AR Castillejo, JL Galán, ... Clinical and Translational Oncology 10, 47-51, 2008 | 11 | 2008 |